GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Tatva Chintan Pharma Chem Ltd (BOM:543321) » Definitions » Net Cash per Share

Tatva Chintan Pharma Chem (BOM:543321) Net Cash per Share : ₹-23.08 (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Tatva Chintan Pharma Chem Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). Tatva Chintan Pharma Chem's Net Cash per Share for the quarter that ended in Sep. 2024 was ₹-23.08.

The historical rank and industry rank for Tatva Chintan Pharma Chem's Net Cash per Share or its related term are showing as below:

During the past 6 years, the highest Price-to-Net-Cash Ratio of Tatva Chintan Pharma Chem was 118.14. The lowest was 79.85. And the median was 99.00.

BOM:543321's Price-to-Net-Cash is not ranked *
in the Chemicals industry.
Industry Median: 9.11
* Ranked among companies with meaningful Price-to-Net-Cash only.

Tatva Chintan Pharma Chem Net Cash per Share Historical Data

The historical data trend for Tatva Chintan Pharma Chem's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tatva Chintan Pharma Chem Net Cash per Share Chart

Tatva Chintan Pharma Chem Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Net Cash per Share
Get a 7-Day Free Trial -60.28 -63.42 -54.66 -91.52 -15.38

Tatva Chintan Pharma Chem Quarterly Data
Mar19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.40 - -15.38 - -23.08

Competitive Comparison of Tatva Chintan Pharma Chem's Net Cash per Share

For the Specialty Chemicals subindustry, Tatva Chintan Pharma Chem's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tatva Chintan Pharma Chem's Price-to-Net-Cash Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Tatva Chintan Pharma Chem's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where Tatva Chintan Pharma Chem's Price-to-Net-Cash falls into.



Tatva Chintan Pharma Chem Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

Tatva Chintan Pharma Chem's Net Cash per Share for the fiscal year that ended in Mar. 2024 is calculated as

Net Cash per Share (A: Mar. 2024 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(456.68-816.36-0)/23.3921
=-15.38

Tatva Chintan Pharma Chem's Net Cash per Share for the quarter that ended in Sep. 2024 is calculated as

Net Cash per Share (Q: Sep. 2024 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(154.4-694.18-0)/23.3921
=-23.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tatva Chintan Pharma Chem  (BOM:543321) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.


Tatva Chintan Pharma Chem Net Cash per Share Related Terms

Thank you for viewing the detailed overview of Tatva Chintan Pharma Chem's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Tatva Chintan Pharma Chem Business Description

Traded in Other Exchanges
Address
Plot No. 353, Makarpura GIDC, Vadodara, GJ, IND, 390010
Tatva Chintan Pharma Chem Ltd is a specialty chemicals manufacturing company engaged in the manufacturing and selling of specialty chemicals, Pharma and Agro intermediates, Quaternary Compounds, and Quats. The company's product portfolio includes structure-directing agents, phase transfer catalysts, electrolyte salts for supercapacitor batteries, pharmaceutical and agrochemical intermediates and other specialty chemicals. The company sells its products in domestic as well as overseas markets, with the majority of revenue coming from overseas markets.

Tatva Chintan Pharma Chem Headlines

No Headlines